Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial

INTRODUCTION: Estrogen inhibition is effective in preventing breast cancer in only up to 50% of women with precancerous lesions and many experience side effects that are poorly tolerated. As insulin-like growth factor I (IGF-I) underlies both estrogen and progesterone actions and has other direct ef...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Breast Cancer Res
المؤلفون الرئيسيون: Singh, Baljit, Smith, Julia A, Axelrod, Deborah M, Ameri, Pietro, Levitt, Heather, Danoff, Ann, Lesser, Martin, de Angelis, Cristina, Illa-Bochaca, Irineu, Lubitz, Sara, Huberman, Daniel, Darvishian, Farbod, Kleinberg, David L
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2014
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4303192/
https://ncbi.nlm.nih.gov/pubmed/25385439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0463-1
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة